Table 8.
Clinical and endoscopic features of the study population: Association with deaths
| Parameter | Survivors (no. pts, %) | Deaths (no. pts, %) | Total no. patients, % | Total (% out of entire batch) | P value |
| Lesion | 1453 (91.90) | 128 (8.10) | 1581 (100) | 100 | 0.001 |
| Rockall score | 1442 (92.61) | 115 (7.39) | 1557 (100) | 100 | < 0.001 |
| Simple therapy | 160 (91.95) | 14 (8.05) | 174 (100) | 11.01 | 0.069 |
| Combined therapy | 355 (94.66) | 20 (5.34) | 375 (100) | 23.72 | 0.209 |
| SBP < 100 mmHg | 216 (75) | 72 (25) | 288 (100) | 18.22 | < 0.001 |
| Pulse > 100 beats per minute | 392 (84.67) | 71 (15.53) | 463 (100) | 29.32 | < 0.001 |
| Rebleeding | 109 (88.62) | 14 (11.38) | 123 (100) | 7.78 | 0.164 |
| Hospitalization length | 1449 (91.94) | 127 (8.06) | 1576 (100) | 100 | < 0.001 |
| No. blood units | 1452 (91.96) | 127 (8.04) | 1579 (100) | 100 | < 0.001 |
| Aspirin | 301 (95.56) | 14 (4.44) | 315 (100) | 19.92 | 0.028 |
| NSAIDs | 237 (96.73) | 8 (3.27) | 245 (100) | 15.50 | 0.003 |
| Surgery | 51 (100) | 0.00 (0.00) | 51 (100) | 3.23 | 0.031 |
| Cardiovascular comorbidities | 895 (91.70) | 81 (8.30) | 976 (100) | 61.73 | 0.707 |
| Diabetes mellitus | 268 (90.54) | 28 (9.46) | 296 (100) | 18.72 | 0.340 |
| Respiratory comorbidities | 156 (75.73) | 50 (24.27) | 206 (100) | 13.03 | < 0.001 |
| Renal comorbidities | 285 (86.36) | 45 (13.64) | 330 (100) | 20.87 | < 0.001 |
| Liver cirrhosis | 115 (81.56) | 26 (18.44) | 141 (100) | 8.92 | < 0.001 |
| Neoplasias | 225 (87.89) | 31 (12.11) | 256 (100) | 16.19 | 0.010 |
| Neurologic comorbidities | 193 (90.19) | 21 (9.81) | 214 (100) | 13.54 | 0.322 |
| Obesity | 127 (94.78) | 7 (5.22) | 134 (100) | 8.48 | 0.203 |
| Sepsis | 25 (53.19) | 22 (46.81) | 47 (100) | 2.97 | < 0.001 |
| Acute pancreatitis | 4 (50) | 4 (50) | 8 (100) | 0.51 | < 0.001 |
| Acute abdomen | 5 (83.33) | 1 (16.67) | 6 (100) | 0.38 | 0.441 |
SBP: Systolic blood pressure; NSAIDs: Non-steroidal anti-inflammatory drugs.